Commitments and Contingencies (Details) |
6 Months Ended | |
|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
kg
|
|
| Commitments and Contingencies Disclosure [Abstract] | ||
| Commitment to purchase API | kg | 1,450 | |
| Purchase obligation | $ 10,200,000 | |
| Other losses for contingent liability | $ 0 | |
| Other provisions for a loss contingency | $ 0 |
| X | ||||||||||
- Definition Purchase Obligation, Additional Active Pharmaceutical Ingredient Committed To Purchase No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of loss (reversal of loss) recognized for loss contingency liability. Includes, but is not limited to, effect of revision in previously reported estimate. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|